Sajile, Fatima Romaisa S.

HRN: 27-85-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2025
CEFUROXIME 750MG (VIAL)
09/25/2025
10/08/2025
IV
440mg
Q8
Open Fracture
Checking Initial Appropriateness 
09/25/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/25/2025
10/08/2025
IV
130mg
Q6h
Open Fracture
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: